Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alkermes Plc
(NQ:
ALKS
)
23.37
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
23.37
Bid (Size)
22.71 (2)
Ask (Size)
31.00 (1)
Prev. Close
23.37
Today's Range
23.37 - 23.37
52wk Range
22.01 - 32.88
Shares Outstanding
166,121,384
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
6 Analysts Assess Alkermes: What You Need To Know
July 15, 2024
Via
Benzinga
"Rule Breaker Investing" Stock Pick Review: The Big One
July 15, 2024
Looking back at 30 five-stock samplers picked from 2015 to 2021.
Via
The Motley Fool
Performance
YTD
-18.34%
-18.34%
1 Month
-6.56%
-6.56%
3 Month
-2.71%
-2.71%
6 Month
-15.81%
-15.81%
1 Year
-23.58%
-23.58%
More News
Read More
NASDAQ:ALKS is an undervalued gem with solid fundamentals.
July 11, 2024
Via
Chartmill
When you look at NASDAQ:ALKS, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
June 19, 2024
Via
Chartmill
The Analyst Landscape: 7 Takes On Alkermes
June 17, 2024
Via
Benzinga
6 Analysts Assess Alkermes: What You Need To Know
May 23, 2024
Via
Benzinga
7 Analysts Assess Alkermes: What You Need To Know
May 02, 2024
Via
Benzinga
Exploring growth characteristics of ALKERMES PLC (NASDAQ:ALKS).
May 02, 2024
Via
Chartmill
Exploring growth characteristics of ALKERMES PLC (NASDAQ:ALKS).
April 10, 2024
Via
Chartmill
In a market where value is scarce, NASDAQ:ALKS offers a refreshing opportunity with its solid fundamentals.
May 29, 2024
Via
Chartmill
3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
May 25, 2024
Via
InvestorPlace
Investors should take notice of NASDAQ:ALKS—it offers a great deal for the fundamentals it presents.
May 08, 2024
Via
Chartmill
ALKS Stock Earnings: Alkermes Misses EPS, Misses Revenue for Q1 2024
May 01, 2024
Via
InvestorPlace
Investors should take notice of NASDAQ:ALKS—it offers a great deal for the fundamentals it presents.
April 17, 2024
Via
Chartmill
Alkermes' Sleeping Disorder Studies' Data Look Excellent, Analyst Says
April 09, 2024
Via
Benzinga
Breaking Down Alkermes: 5 Analysts Share Their Views
April 09, 2024
Via
Benzinga
Is NASDAQ:ALKS suited for growth investing?
March 20, 2024
Via
Chartmill
The Analyst Verdict: Alkermes In The Eyes Of 4 Experts
March 19, 2024
Via
Benzinga
When you look at NASDAQ:ALKS, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
March 27, 2024
Via
Chartmill
A Look Into Healthcare Sector Value Stocks
March 11, 2024
Via
Benzinga
Amicus Therapeutics Stock Sees RS Rating Improve To 74
March 05, 2024
Via
Investor's Business Daily
NASDAQ:ALKS stands out as a stock that provides good value for the fundamentals it showcases.
March 05, 2024
Via
Chartmill
Exploring NASDAQ:ALKS's growth characteristics.
February 28, 2024
Via
Chartmill
Beam Therapeutics Stock Jumps To Higher RS Level On Earnings Beat
February 27, 2024
Via
Investor's Business Daily
Agios Pharmaceuticals Stock Earns RS Rating Upgrade; Hits Key Benchmark
February 23, 2024
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
